These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2348235)

  • 1. A comparative autoradiographic study demonstrating differential intratumor localization of monoclonal antibodies to cell surface (Lym-1) and intracellular (TNT-1) antigens.
    Chen FM; Epstein AL; Li Z; Taylor CR
    J Nucl Med; 1990 Jun; 31(6):1059-66. PubMed ID: 2348235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate.
    LeBerthon B; Khawli LA; Alauddin M; Miller GK; Charak BS; Mazumder A; Epstein AL
    Cancer Res; 1991 May; 51(10):2694-8. PubMed ID: 2021947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis treatment of ME-180 human cervical carcinoma model with 131I-labeled TNT-1 monoclonal antibody.
    Chen FM; Taylor CR; Epstein AL
    Cancer Res; 1989 Aug; 49(16):4578-85. PubMed ID: 2743341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
    DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
    Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.
    Hu P; Glasky MS; Yun A; Alauddin MM; Hornick JL; Khawli LA; Epstein AL
    Hum Antibodies Hybridomas; 1995; 6(2):57-67. PubMed ID: 7492752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antitumor effects of interleukin 2 and the monoclonal Lym-1 against human Burkitt lymphoma cells in vitro and in vivo.
    Gill I; Agah R; Hu E; Mazumder A
    Cancer Res; 1989 Oct; 49(19):5377-9. PubMed ID: 2788499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a monoclonal antibody, TV-1, directed against the basement membrane of tumor vessels, and its use to enhance the delivery of macromolecules to tumors after conjugation with interleukin 2.
    Epstein AL; Khawli LA; Hornick JL; Taylor CR
    Cancer Res; 1995 Jun; 55(12):2673-80. PubMed ID: 7780984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One step forward with nonspecifically-specific monoclonal antibodies.
    Narula J; Khaw BA
    J Nucl Med; 1990 Jun; 31(6):1066-8. PubMed ID: 2189963
    [No Abstract]   [Full Text] [Related]  

  • 9. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
    Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
    Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor localization by combinations of monoclonal antibodies in a new human colon carcinoma cell line (LIM1899).
    Andrew SM; Teh JG; Johnstone RW; Russell SM; Whitehead RH; McKenzie IF; Pietersz GA
    Cancer Res; 1990 Sep; 50(17):5225-30. PubMed ID: 2386931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
    Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
    Yokota T; Milenic DE; Whitlow M; Wood JF; Hubert SL; Schlom J
    Cancer Res; 1993 Aug; 53(16):3776-83. PubMed ID: 8339291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice.
    Hwang KM; Fodstad O; Oldham RK; Morgan AC
    Cancer Res; 1985 Sep; 45(9):4150-5. PubMed ID: 4028007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of radioantibody localization and cell viability in a xenografted human cancer model as measured by whole-body autoradiography.
    Fand I; Sharkey RM; Primus FJ; Cohen SA; Goldenberg DM
    Cancer Res; 1987 Apr; 47(8):2177-83. PubMed ID: 3548950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration and binding of antibodies in experimental human solid tumors grown in mice.
    Ong GL; Mattes MJ
    Cancer Res; 1989 Aug; 49(15):4264-73. PubMed ID: 2743313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice.
    Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Yamamuro T; Toyama S
    Cancer Res; 1989 Apr; 49(7):1752-7. PubMed ID: 2924318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model.
    Hooijberg E; van den Berk PC; Sein JJ; Wijdenes J; Hart AA; de Boer RW; Melief CJ; Hekman A
    Cancer Res; 1995 Feb; 55(4):840-6. PubMed ID: 7531616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumors.
    Sharifi J; Khawli LA; Hu P; King S; Epstein AL
    Hybrid Hybridomics; 2001; 20(5-6):305-12. PubMed ID: 11839248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy.
    Griffith MH; Yorke ED; Wessels BW; DeNardo GL; Neacy WP
    J Nucl Med; 1988 Nov; 29(11):1795-809. PubMed ID: 3263479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.